These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 8952630
1. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines]. Bachmann-Moisson N, Barberi-Heyob M, Merlin JL, Ledrich ML, Batt AM, Guillemin F. Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630 [Abstract] [Full Text] [Related]
3. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC. Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [Abstract] [Full Text] [Related]
4. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Reddel RR, Murphy LC, Hall RE, Sutherland RL. Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620 [Abstract] [Full Text] [Related]
6. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines. Pihie AH, Stanslas J, Din LB. Anticancer Res; 1998 Apr; 18(3A):1739-43. PubMed ID: 9673398 [Abstract] [Full Text] [Related]
7. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Reddel RR, Sutherland RL. Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038 [Abstract] [Full Text] [Related]
8. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC. Anticancer Res; 2006 Oct 15; 26(3A):1773-84. PubMed ID: 16827106 [Abstract] [Full Text] [Related]
9. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture. Jain PT, Pento JT, Magarian RA. Anticancer Res; 1992 Oct 15; 12(3):585-90. PubMed ID: 1622114 [Abstract] [Full Text] [Related]
10. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines. ter Haar E, Day BW. Anticancer Res; 1996 Oct 15; 16(3A):1107-15. PubMed ID: 8702221 [Abstract] [Full Text] [Related]
11. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse. Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC. Cancer Res; 1988 Feb 15; 48(4):812-5. PubMed ID: 3338079 [Abstract] [Full Text] [Related]
13. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen. Morrissey JJ, Raney S. Cell Biol Int; 1998 Feb 15; 22(6):413-9. PubMed ID: 10328849 [Abstract] [Full Text] [Related]
14. Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. Taylor CM, Blanchard B, Zava DT. Cancer Res; 1984 Apr 15; 44(4):1409-14. PubMed ID: 6704959 [Abstract] [Full Text] [Related]
16. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Awad AB, Barta SL, Fink CS, Bradford PG. Mol Nutr Food Res; 2008 Apr 15; 52(4):419-26. PubMed ID: 18338406 [Abstract] [Full Text] [Related]
17. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells. Chang SB, Miron P, Miron A, Iglehart JD. J Surg Res; 2007 Mar 15; 138(1):37-44. PubMed ID: 17109887 [Abstract] [Full Text] [Related]
18. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M. Cancer Res; 1999 Aug 01; 59(15):3646-51. PubMed ID: 10446976 [Abstract] [Full Text] [Related]
19. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Mandlekar S, Yu R, Tan TH, Kong AN. Cancer Res; 2000 Nov 01; 60(21):5995-6000. PubMed ID: 11085519 [Abstract] [Full Text] [Related]
20. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. Johnston SR, Lu B, Scott GK, Kushner PJ, Smith IE, Dowsett M, Benz CC. Clin Cancer Res; 1999 Feb 01; 5(2):251-6. PubMed ID: 10037172 [Abstract] [Full Text] [Related] Page: [Next] [New Search]